Seres Therapeutics Inc — Cash Flow (NASDAQ:MCRB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 93.61 M6.69 M228.82 M117.35 M148.61 M1.12 M 1.12 M Cash from investing activities 158.89 M64.09 M82.43 M10.58 M142.29 M42 K 42 K Cash from financing activities 303.42 M1.18 M129.6 M71.7 M90.37 M13.9 M 13.9 M Free cash flow 93.02 M-2.88 M219 M109.38 M148.23 M865 K 865 K

News

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Seres stock falls after pausing Phase 2 study and cutting workforce by 30%

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'

Seres Therapeutics publishes new insights on VOWST mechanism

3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround

Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director

Seres to present new data on SER-155 bloodstream infection study

Seres Therapeutics announces workforce reduction to extend cash runway

Factbox-More companies adopt co-CEO structure

Canaccord Genuity raises Seres Therapeutics stock price target to $22 on FDA hopes

Seres Therapeutics advances SER-155 protocol after FDA feedback

Factbox-More companies adopt co-CEO structure